Christopher Paige's most recent trade in Tectonic Therapeutic Inc. was a trade of 17,643 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 6, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tectonic Therapeutic Inc. | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,643 | 17,643 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 17,438 | 17,438 | - | - | Stock Option (Right to Buy) | |
Tectonic Therapeutic Inc. | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) |